Lipton — Plant Butter with Olive Oil 79% Plant-based Oil Spread, Plant Butter
by LiptonMRT 176 Panel Triggers Identified
Clinical Product Assessment
Lipton manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 4 MRT-tested substances. Soybean is present in the oil blend and via soy lecithin; Olive is present in two forms within the oil blend. Citric Acid is included as an acidulant, and Lecithin (Soy) is a specific chemical trigger. The presence of ‘natural flavor’ adds further uncertainty. Due to the high number of triggers, this product is unsuitable for Phase 1 or 2. This is procedural data interpretation, not medical guidance.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 4
- Safe Ingredients: 8
- Unknown/Ambiguous: 1 (natural flavor)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel. Each ingredient is mapped to its corresponding panel analyte:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| soybean | Soybean | Direct Match |
| olive | Olive | Direct Match |
| extra virgin olive oil | Olive | Direct Match |
| soy lecithin | Lecithin (Soy), Soybean | Direct Match |
| citric acid | Citric Acid | Chemical Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel and may contain hidden triggers: natural flavor. Patients should treat these as potential triggers until MRT testing confirms safety. Common examples include ‘natural flavors’ (which can contain any of the 176 tested substances) and ‘spices’ (which may include tested spices like cinnamon, cumin, or black pepper).
LEAP Protocol Guidance
With 4 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2 of the LEAP protocol. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist for personalized evaluation based on their individual MRT results.
UPC Code: 027400000249
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient in the product was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives. Ingredient-to-panel mapping uses direct matching, derivative identification (e.g., ‘whey’ maps to Cow’s Milk), and chemical compound recognition. Hidden trigger sources such as ‘natural flavors’ and ‘spices’ are flagged as unknown variables requiring individual verification.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Soy-derived ingredients appear in a wide range of processed foods including soy lecithin, soybean oil, and textured soy protein. One of the most prevalent hidden triggers.
Olive is tested on the MRT panel. Includes olive oil (one of the most common cooking oils), table olives, and olive-derived ingredients. A staple of Mediterranean diets.
Soy lecithin is one of the most ubiquitous food additives, used as an emulsifier in chocolate, baked goods, and margarine. Even small amounts can trigger mediator release in sensitive patients.
A chemical additive tested on the MRT panel. Industrially produced from Aspergillus niger mold, not citrus fruit. Found in beverages, canned goods, candy, and as a preservative in thousands of products.
What This Means For Your Diet
With 4 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 4 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from Lipton
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners